|
|
||||||||


1 INSERM Unit 271, 151 Cours Albert Thomas, 69003 Lyon, France
2 Ecole Nationale Vétérinaire, Marcy l'Etoile, France
3 Department of Internal Medicine II/Molecular Biology, University Hospital, Freiburg, Germany
4 CHU Lyon, France
5 Novotec, Lyon, France
6 Laboratoires Marcel Mérieux, Lyon, France
Correspondence
Lucyna Cova
cova{at}lyon.inserm.fr
Gamma interferon (IFN-
) expression plays a crucial role in the control of mammalian hepatitis B virus (HBV) infection. However, the role of duck INF-
(DuIFN-
) in the outcome of duck HBV (DHBV) infection, a reference model for hepadnavirus replication studies, has not yet been investigated. This work explored the dynamics of DuIFN-
expression in liver and peripheral blood mononuclear cells (PBMCs) during resolution of DHBV infection in adolescent ducks in relation to serum and liver markers of virus replication, histological changes and humoral response induction. DHBV infection of 3-week-old ducks resulted in transient expression of intrahepatic preS protein (days 314) and mild histological changes. Low-level viraemia was detected only during the first 10 days of infection and was accompanied by early anti-preS antibody response induction. Importantly, a strong increase in intrahepatic DuIFN-
RNA was detected by real-time RT-PCR at days 614, which coincided with a sharp decrease in both viral DNA and preS protein in the liver. Interestingly, liver DuIFN-
expression remained augmented to the end of the follow-up period (day 66) and correlated with portal lymphocyte infiltration and persistence of trace quantities of intrahepatic DHBV DNA in animals that had apparently completely resolved the infection. Moreover, in infected ducks, a moderate increase was detected in the levels of DuIFN-
in PBMCs (days 1214), which coincided with the peak in liver DuIFN-
RNA levels. These data reveal that increased DuIFN-
expression in liver and PBMCs is concomitant with viral clearance, characterizing the resolution of infection, and provide new insights into the hostvirus interactions that control DHBV infection.
These authors contributed equally to this work.
This article has been cited by other articles:
![]() |
A. Thermet, T. Buronfosse, B. Werle-Lapostolle, M. Chevallier, P. Pradat, C. Trepo, F. Zoulim, and L. Cova DNA vaccination in combination or not with lamivudine treatment breaks humoral immune tolerance and enhances cccDNA clearance in the duck model of chronic hepatitis B virus infection J. Gen. Virol., May 1, 2008; 89(5): 1192 - 1201. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |